Dr. Viscuse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Summary
- Dr. Paul Viscuse is an oncologist at the University of Virginia in Charlottesville, VA. He received his medical degree from Marshall University School of Medicine. He specializes in genitourinary cancers with a focus on clinical investigation and translational research.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2022
- University of Texas M.D. Anderson Cancer CenterOncology, 2022
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
- Marshall University Joan C. Edwards School of MedicineClass of 2016
Certifications & Licensure
- VA State Medical License 2022 - 2026
- TX State Medical License 2019 - 2023
- MN State Medical License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Attitude, Committment, & Excellence (ACE) Award Mayo Clinic, 2017-2018
- Academic Achievement Award Marshall University Joan C. Edwards School of Medicine, 2015-2016
Publications & Presentations
PubMed
- 5 citationsPersistent ST-Segment Elevation: A Pandora's Box.Paul V. Viscuse, Thomas A. Foley, Hector I. Michelena
Circulation. 2018-09-11 - 6 citationsGenotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components.Rama Soundararajan, Paul Viscuse, Patrick Pilie, Jingjing Liu, Souzana Logotheti
Cancers. 2022-06-30 - 34 citationsClinical considerations for the management of androgen indifferent prostate cancerJacob E. Berchuck, Paul V. Viscuse, Himisha Beltran, Ana Aparicio
Prostate Cancer and Prostatic Diseases. 2021-02-10
Press Mentions
- Paul Viscuse, MD, on Androgen-Indifferent Prostate CancersSeptember 8th, 2021
Committees
- Medical Student Representative, Curriculum Committee 2012 - 2016
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: